相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer
Ang Gao et al.
NANO LETTERS (2020)
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Jing Gao et al.
ACTA PHARMACOLOGICA SINICA (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
Chuanhui Han et al.
NATURE IMMUNOLOGY (2020)
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
Brian Diskin et al.
NATURE IMMUNOLOGY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Near-Infrared-II Molecular Dyes for Cancer Imaging and Surgery
Shoujun Zhu et al.
ADVANCED MATERIALS (2019)
Engineering nanoparticles to locally activate T cells in the tumor microenvironment
Dangge Wang et al.
SCIENCE IMMUNOLOGY (2019)
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
Nicolas Jacquelot et al.
CELL RESEARCH (2019)
Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
Fangyuan Zhou et al.
ADVANCED MATERIALS (2019)
Dendritic cell subsets in T cell programming: location dictates function
S. C. Eisenbarth
NATURE REVIEWS IMMUNOLOGY (2019)
An Efficient 1064 nm NIR-II Excitation Fluorescent Molecular Dye for Deep-Tissue High-Resolution Dynamic Bioimaging
Benhao Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Dendritic cells in cancer immunotherapy
Camille M. Le Gall et al.
NATURE MATERIALS (2018)
Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells
Debangshu Samanta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Tingting Wang et al.
NATURE COMMUNICATIONS (2018)
A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues
Hao Wan et al.
NATURE COMMUNICATIONS (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma
Michael Cerezo et al.
NATURE MEDICINE (2018)
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Yuchen Fan et al.
NANO LETTERS (2017)
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
Hengfeng Yuan et al.
NATURE NANOTECHNOLOGY (2017)
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg et al.
CELL REPORTS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Programmed Multiresponsive Vesicles for Enhanced Tumor Penetration and Combination Therapy of Triple-Negative Breast Cancer
Fangyuan Zhou et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
A small-molecule dye for NIR-II imaging
Alexander L. Antaris et al.
NATURE MATERIALS (2016)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
R. Dixon Dorand et al.
SCIENCE (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
Liposome-protein corona in a physiological environment: Challenges and opportunities for targeted delivery of nanomedicines
Giulio Caracciolo
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Using tumour phylogenetics to identify the roots of metastasis in humans
Kamila Naxerova et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Immunological hallmarks of stromal cells in the tumour microenvironment
Shannon J. Turley et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Tumor metastasis: moving new biological insights into the clinic
Liling Wan et al.
NATURE MEDICINE (2013)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal
Brian T. Fife et al.
NATURE IMMUNOLOGY (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
Jianda Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
CTLA-4: new insights into its biological function and use in tumor immunotherapy
JG Egen et al.
NATURE IMMUNOLOGY (2002)
Effector and memory T-cell differentiation: Implications for vaccine development
SM Kaech et al.
NATURE REVIEWS IMMUNOLOGY (2002)
分享论文
